Low-dose FK506 after contralateral C7 transfer to the musculocutaneous nerve using two different tubes: A study in rats

Annals of Plastic Surgery

Volumn 64, Issue 5, 2010, Pages 622-631

  Terzis, Julia K ^a   Konofaos, Petros ^a  

^a EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

Author keywords

CC7 transfer to MC nerve; Collagen tube; FK506; Long nerve gaps (4 cm); Poly DL lactide caprolactone tube; Tubulization repair

Indexed keywords

COLLAGEN; LACTIDE CAPROLACTONE COPOLYMER; LACTIDE-CAPROLACTONE COPOLYMER; POLYESTER; TACROLIMUS;

ANALYSIS OF VARIANCE; ANIMAL; ARTICLE; BRACHIAL PLEXUS; DRUG EFFECT; ELECTROMYOGRAPHY; MALE; METHODOLOGY; NERVE REGENERATION; NERVE TRANSPLANTATION; NONPARAMETRIC TEST; ORGAN SIZE; RAT; SPRAGUE DAWLEY RAT;

ANALYSIS OF VARIANCE; ANIMALS; COLLAGEN; ELECTROMYOGRAPHY; MALE; MUSCULOCUTANEOUS NERVE; NERVE REGENERATION; NERVE TRANSFER; ORGAN SIZE; POLYESTERS; RATS; RATS, SPRAGUE-DAWLEY; STATISTICS, NONPARAMETRIC; TACROLIMUS;

EID: 77951765613     PISSN: 01487043     EISSN: None     Source Type: Journal    
DOI: 10.1097/SAP.0b013e3181b6aae1     Document Type: Conference Paper

References (75)

1. Terzis J, Faibisoff B, Williams B. The nerve gap: suture under tension vs graft. Plast Reconstr Surg. 1975;56:166-170.
2. Lundborg G. A 25-year perspective of peripheral nerve surgery: evolving neuroscientific concepts and clinical significance. J Hand Surg Am. 2000;25: 391-414.
3. Gluck T. Ueber neuroplastic auf den wege der transplantation. Arch Klin Chir. 1880;25:606.
4. Vanlair C. De la regeneration des nerfs périphériques par le procédé de la suture tubulaire. Arch Biol. 1882;3:379-496.
5. Vanlair C. De la névrotisation des cartilages osseux de la suture tubulaire. Arch Phys. 1882;10:595-614.
6. Foramitti C. Zur techinik der nervennaht. Arch Klin Chir. 1904;73:643-648.
7. Kirk EG, Lewis D. Fascial tubulization in the repair of nerve defects. JAMA. 1915;65:486-492.
8. Garrity RW. The use of plastics and rubber tubing in the management of irreparable nerve injuries. Surg Forum. 1955;6:517-520.
9. Dahlin LB, Anagnostaki L, Lundborg G. Tissue response to silicone tubes used to repair human median and ulnar nerves. Scand J Plast Reconstr Surg Hand Surg. 2001;35:29-34.
10. Tos P, Battiston B, Nicolino S, et al. Comparison of fresh and predegenerated muscle-vein-combined guides for the repair of rat median nerve. Microsurgery. 2007;27:48-55.
11. Danielsson PA, Adolfsson L, Dahlin LB. Different effect on axonal outgrowth of application of non-absorbable or absorbable tubes around a nerve repair. Scand J Plast Reconstr Surg Hand Surg. 2001;35:347-353.
12. Navarro X, Udina E, Ceballos D, et al. Effects of FK506 on nerve regeneration and reinnervation after graft or tube repair of long nerve gaps. Muscle Nerve. 2001;24:905-915.
13. Gold BG. Neuroimmunophilin ligands: evaluation of their therapeutic potential for the treatment of neurological disorders. Expert Opin Investig Drugs. 2000;10:2331-2342.
14. Guo X, Dillman JF, Dawson VL, et al. Neuroimmunophilins. Novel neuroprotective and neuroregenerative targets. Ann Neurol. 2001;50:6-16.
15. Gold BG, Katoh K, Storm-Dickerson T. The immunosuppressant FK506 increases the rate of axonal regeneration in rat sciatic nerve. J Neurosci. 1995;15:7509-7516.
16. Inciong JG, Marrocco WC, Terzis JK. Efficacy of intervention strategies in a brachial plexus global avulsion model in the rat. Plast Reconstr Surg. 2000;105:2059-2071.
17. Papakonstantinou KC, Shiamishis G, Bates M, et al. Distraction osteogenesis using IGF-I after nerve microreconstruction. J Reconstr Microsurg. 2002;18: 401-410.
18. Kalantarian B, Rice DC, Tiangco DA, et al. Gains and losses of the XII-VII component of the "baby-sitter" procedure: a morphometric analysis. J Reconstr Microsurg. 1998;14:459-471.
19. Bertelli JA, Taleb M, Saadi A, et al. The rat brachial plexus and its terminal branches: an experimental model for the study of peripheral nerve regeneration. Microsurgery. 1995;16:77-85.
20. Rodriguez FJ, Valero-Cabre A, Navarro X. Regeneration and functional recovery following peripheral nerve injury. Drug Discov Today Dis Models. 2004;1:177-185.
21. Tos P, Calcagni M, Gigo-Benato D, et al. Use of muscle-vein-combined Y-chambers for repair of multiple nerve lesions: experimental results. Microsurgery. 2004;24:459-464.
22. Varejaö AS, Melo-Pinto P, Meek MF, et al. Methods for the experimental functional assessment of rat sciatic nerve regeneration. Neurol Res. 2004;26: 186-194.
23. Papalia I, Tos P, Scevola A, et al. The ulnar test: a method for the quantitative functional assessment of posttraumatic ulnar nerve recovery in the rat. J Neurosci Methods. 2006;154:198-203.
24. Meek MF, Den Dunnen WF, Robinson PH, et al. Long-term evaluation of functional nerve recovery after reconstruction with a thin-walled biodegradable poly (DL-lactide-e- caprolactone) nerve guide, using walkingtrack analysis and electrostimulation tests. Microsurgery. 1999;19:247-253.
25. Jensen JN, Brenner MJ, Tung TH, et al. Effect of FK506 on peripheral nerve regeneration through long grafts in inbred swine. Ann Plast Surg. 2005;54: 420-427.
26. Jensen JN, Tung TH, Mackinnon SE, et al. Use of anti-CD40 ligand monoclonal antibody as anti-rejection therapy in a murine peripheral nerve allograft model. Microsurgery. 2004;24:309-315.
27. Steiner JP, Hamilton GS, Ross DT, et al. Neurotrophic immunophilin ligands stimulate structural and functional recovery in neurodegenerative animal models. Proc Natl Acad Sci U S A. 1997;94:2019-2024.
28. Gordon T, Fu SY. Long-term response to nerve injury. Adv Neurol. 1997; 72:185-199.
29. Kobayashi J, Mackinnon SE, Watanabe O, et al. The effect of duration of muscle denervation on functional recovery in the rat model. Muscle Nerve. 1997;20:858-866.
30. Sinis N, Schaller HE, Becker ST, et al. Cross-chest median nerve transfer: a new model for the evaluation of nerve regeneration across a 40 mm gap in the rat. J Neurosci Methods. 2006;156:166-172.
31. Sinis N, Schaller HE, Becker ST, et al. Long nerve gaps limit the regenerative potential of bioartificial nerve conduits filled with Schwann cells. Restor Neurol Neurosci. 2007;25:131-141.
32. Grand A, Myckatyn T, Mackinnon S, et al. Axonal regeneration after cold preservation of nerve allografts and immunosuppression with tacrolimus in mice. J Neurosurg. 2002;96:926-932.
33. Lyons WE, George EB, Dawson TM, et al. Immunosuppressant FK506 promotes neurite outgrowth in cultures of PC12 cells and sensory ganglia. Proc Natl Acad Sci U S A. 1994;91:3191-3195.
34. Tanaka K, Fujita N, Higashi Y, et al. Neuroprotective and antioxidant properties of FKBP-binding immunophilin ligands are independent on the FKBP12 pathway in human cells. Neurosci Lett. 2002;330:147-150.
35. Gold BG, Densmore V, Shou W, et al. Immunophilin FK506-binding protein 52 (not FK-506-binding protein 12) mediates the neurotrophic action of FK506. J Pharmacol Exp Ther. 1999;289:1202-1210.
36. Owens-Grillo JK, Hoffmann K, Hutchison KA, et al. The cyclosporin Abinding immunophilin CyP-40 and the FK-506-binding immunophilin hsp56 bind to a common site on hsp90 and exit in independent cytosolic heterocomplexes with the untransformed glucocorticoid receptor. J Biol Chem. 1995;270:20479-20489.
37. Czar MJ, Owens-Grillo JK, Yem AW, et al. The hsp56 immunophilin component of untransformed steroid receptor complexes is localized both to microtubules in the cytoplasm and to the same nonrandom regions within the nucleus as the steroid receptor. Mol Endocrinol. 1994;8:1731-1741.
38. Kralli A, Yamamoto KR. An FK-506-sensitive transporter selectively decreases intracellular levels and potency of steroid hormones. J Biol Chem. 1996;271:17152-17156.
39. Benowitz LI, Routtenberg A. GAP-43: an intrinsic determinant of neuronal development and plasticity. Trends Neurol Sci. 1997;20:84-91.
40. Udina E, Ceballos D, Gold BG, et al. FK-506 enhances reinnervation by regeneration and by collateral sprouting of peripheral nerve fibers. Exp Neurol. 2003;183:220-231.
41. Lundborg G, Rosen B, Dahlin L, et al. Tubular repair of the median or ulnar nerve in the human forearm: a 5-year follow-up. J Hand Surg Br. 2004;29: 100-107.
42. Weber RA, Breidenbach WC, Brown RE, et al. A randomized prospective study of polyglycolic acid conduits for digital nerve reconstruction in humans. Plast Reconstr Surg. 2000;106:1036 -1045; discussion 1046-1048.
43. Mackinnon SE, Dellon AL. Clinical nerve reconstruction with a bioabsorbable polyglycolic acid tube. Plast Reconstr Surg. 1990;85:419-424.
44. Navarro X, Rodriguez FJ, Labrador RO, et al. Peripheral nerve regeneration through bioresorbable and durable nerve guides. J Peripher Nerv Syst. 1996;1:53-64. (Pubitemid 126674021)
45. Rodríguez FJ, Gómez N, Perego G, et al. Highly permeable polylactidecaprolactone nerve guides enhance peripheral nerve regeneration through long gaps. Biomaterials. 1999;20:1489-1500.
46. Matsumoto K, Ohnishi K, Kiyotani T, et al. Peripheral nerve regeneration across an 80-mm gap bridged by a polyglycolic acid (PGA)-collagen tube filled with laminin-coated collagen fibers: a histological and electrophysiological evaluation of regenerated nerves. Brain Res. 2000;868:315-328.
47. Keilhoff G, Stang F, Wolf G, et al. Bio-compatibility of type I/III collagen matrix for peripheral nerve reconstruction. Biomaterials. 2003;24:2779-2787.
48. Bailey SB, Eichler ME, Villadiego A, et al. The influence of fibronectin and laminin during Schwann cell migration and peripheral nerve regeneration through silicon chambers. J Neurocytol. 1993;22:176-184.
49. Kitahara AK, Nishimura Y, Shimizu Y, et al. Facial nerve repair accomplished by the interposition of a collagen nerve guide. J Neurosurg. 2000; 93:113-120.
50. Ahmed MR, Jayakumar R. Peripheral nerve regeneration in cell adhesive peptide incorporated collagen tubes in rat sciatic nerve-early and better functional regain. J Peripher Nerv Syst. 2005;10:390-391.
51. Hall S. Axonal regeneration through acellular muscle grafts. J Anat. 1997; 190(pt 1):57-71.
52. Williams LR, Longo FM, Powell HC, et al. Spatial-temporal progress of peripheral nerve regeneration within a silicone chamber: parameters for a bioassay. J Comp Neurol. 1983;218:460-470.
53. Rodriguez FJ, Verdu E, Ceballos D, et al. Nerve guides seeded with autologous schwann cells improve nerve regeneration. Exp Neurol. 2000;161:571-584.
54. Bora FW, Bedner JM, Osterman AL, et al. Prosthetic nerve grafts: a resorbable tube as an alternative to autogenous nerve grafting. J Hand Surg Am. 1987;12(5 pt 1):685-692.
55. Den Dunnen WF, Van Der Lei B, Schakenraad JM, et al. Long-term evaluation of the nerve regeneration in a biodegradable nerve guide. Microsurgery. 1993;14:508-515.
56. Evans GR, Brandt K, Widmer MS, et al. In vivo evaluation of (L-lactic acid) porous conduits for peripheral nerve regeneration. Biomaterials. 1999;20: 1109-1115.
57. Lundborg G, Dahlin LB, Danielsen N, et al. Nerve regeneration in silicone chambers: influence of gap length and of distal stump components. Exp Neurol. 1982;76:361-375.
58. Molander H, Engkvist O, Hagglund J, et al. Nerve repair using a polyglactin tube and nerve graft: an experimental study in the rabbit. Biomaterials. 1983;4:276-280.
59. Seckel BR, Chiu TH, Nyilas E, et al. Nerve regeneration through synthetic biodegradable nerve guides: regulation by the target organ. Plast Reconstr Surg. 1984;74:173-181.
60. Brown RE, Eldmann D, Lyons SF, et al. The use of cultured Schwann cells in nerve repair in a rabbit hind-limb model. J Reconstr Microsurg. 1996;12: 149-152.
61. Dellon AL, Mackinnon SE. An alternative to the classical nerve graft for the management of the short nerve gap. Plast Reconstr Surg. 1988;82:849-856.
62. Kiyotani T, Teramachi M, Takimoto Y, et al. Nerve regeneration across a 25-mm gap bridged by a polyglycolic acid collagen tube: a histological evaluation of regenerated nerves. Brain Res. 1996;740:66-74.
63. Mackinnon SE, Dellon AL. A study of nerve regeneration across collagen nerve guide tube, synthetic (Maxon) and biologic (collagen) nerve conduits for nerve gaps up to 5 cm in the primate. J Reconstr Microsurg. 1990;6:117-121.
64. Suzuki Y, Tanihara M, Ohnishi K, et al. Cat peripheral nerve regeneration across 50 mm gap repaired with a novel guide composed of freeze-dried alginate gel. Neurosci Lett. 1999;259:75-78.
65. Madison RD, Archibald SJ, Lacin R, et al. Factors contributing to preferential motor reinnervation in the primate peripheral nervous system. J Neurosci. 1999;19:11007-11016.
66. Kakinoki R, Nishijima N, Ueba Y, et al. Nerve regeneration over a 25 mm gap in rat sciatic nerves using tubes containing blood vessels: the possibility of clinical application. Int Orthop. 1997;21:332-336.
67. Danielsen N, Lundborg G, Frizell M. Nerve repair and axonal transport. Distribution of axonally transported proteins during maturation period in regenerating rabbit hypoglossal nerve. J Neurol Sci. 1986;73:269-277.
68. Gu YD, Ma MK. Nerve transfer for treatment of root avulsion of the brachial plexus: experimental studies in a rat model. J Reconstr Microsurg. 1991;7:15-22.
69. Krarup C, Archibald SJ, Madison RD. Factors that influence peripheral nerve regeneration: an electrophysiological study of the monkey median nerve. Ann Neurol. 2002;51:69-81.
70. Iwasaki Y, Ichikawa Y, Igarashi O, et al. Neuroprotective actions of FK506 and cyclosporin A on motor neuron survival following neonatal axotomy. Neurol Res. 2002;24:573-576.
71. Doolabh VB, Mackinnon SE. FK506 accelerates functional recovery following nerve grafting in a rat model. Plast Reconstr Surg. 1999;103:1928-1936.
72. Udina E, Ceballos D, Verdu E, et al. Bimodal dose-dependence of FK506 on the rate of axonal regeneration in mouse peripheral nerve. Muscle Nerve. 2002;26:348-355.
73. Fansa H, Keilhoff G, Altmann S, et al. The effect of the immunosuppressant FK 506 on peripheral nerve regeneration following nerve grafting. J Hand Surg Br. 1999;24:38-42. (Pubitemid 29084344)
74. Chunasuwankul R, Ayrout C, Dereli Z, et al. Low dose discontinued FK506 treatment enhances peripheral nerve regeneration. Int Surg. 2002;87:274-278.
75. Constantini LC, Chaturvedi P, Armistead DM, et al. A novel immunophilin ligand: distinct branching effects on dopaminergic neurons in culture and neurotrophic actions after oral administration in an animal model of Parkinson's disease. Neurobiol Dis. 1998;5:97-106.